Back to results
US 2025/0172552 A1Published application
Monoclonal antibodies for detecting kawasaki disease antigens
AssigneesAnn & Robert H. Lurie Children's Hospital of Chicago, Loyola University of Chicago
InventorsAnne H. Rowley, Stanford T. Shulman, Susan C. Baker
Life of this patent
Estimating the term…
Abstract
The present disclosure provides monoclonal antibodies that target intracytoplasmic inclusion bodies in KD and methods for their use. Wherein an isolated antibody or antigen binding fragment thereof comprises: a heavy chain variable domain comprising: CDRH1, CDRH and CDRH3 sequences; and a light chain variable domain comprising: CDRL1, CDRL2, and CDRL3 sequences.
Claims30
An isolated antibody or antigen binding fragment thereof comprising:
- a heavy chain variable domain comprising:
- a CDRH1 region selected from the group consisting of SEQ ID NOs:
- 2, 14, 22, 30, 42, 50, 62, 78, 86, 93, 101, 123, 126, 139, 149, 152, 164, 176, 186, and 205;
- a CDRH2 region selected from the group consisting of SEQ ID NOs:
- 74, 15, 23, 31, 35, 43, 51, 63, 70, 75, 79, 87, 94, 102, 111, 114, 127, 136, 140, 153, 165, 168, 177, 183, 187, 193, 206, and 212;
- a CDRH3 region selected from the group consisting of SEQ ID NOs:
- 4, 16, 14, 32, 36, 44, 52, 64, 71, 76, 80, 88, 95, 103, 112, 115, 124, 128, 137, 141, 150, 154, 166, 169, 178, 184, 188, 194, 207, 210, and 213;
- and
- a light chain variable domain comprising:
- a CDRL1 region selected from the group consisting of SEQ ID NOs:
- 6, 10, 18, 26, 37, 46, 54, 58, 66, 38, 82, 97, 105, 46, 119, 129, 132, 143, 146, 156, 160, 171, 180, 190, 197, 201, and 215;
- a CDRL2 region selected from the group consisting of SEQ ID NOs:
- 7, 11, 27, 28, 47, 55, 59, 67, 39, 83, 98, 106, 120, 133, 157, 161, 198, 202, and 208;
- and
- a CDRL3 region selected from the group consisting of SEQ ID NOs:
- 8, 12, 20, 28, 39, 48, 56, 60, 68, 73, 84, 99, 107, 109, 117, 121, 130, 134, 144, 147, 158, 162, 172, 174, 181, 191, 199, 203, and 216.
13 more elements
A peptide comprising SEQ ID NO:
- 281 or a peptide comprising a sequence with 95% similarity to SEQ ID NO:
- 281.
Dependencies are inferred from the claim text.